Kangfeng Biotechnology (09926.HK) has granted 7.115 million share options and 3.42 million restricted stock units.

Wisdom Financial News APP reports that Kangfang Biology (09926.HK) announced that on May 24, 2025, the company granted 7.115 million share options to 114 grantees (including directors) under its stock option plan. The grantees must accept the options before they can be exercised. The exercise price of the options is HK$84.60 per share and they have a validity period of 10 years. Among them, 4.08 million share options were granted to directors.